
Ultragenyx Pharmaceutical Inc.
USD28.62
+0.09 (+0.32%)
CEO
Emil D. Kakkis
IPO Date
2014-01-31
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$29.00
Prev. Close
$28.53
Day Low
$28.23
Day High
$29.10
52W Low
$18.29
52W High
$39.89
Market Cap
$2.82B
Volume
2.22M
| 1 Oct 2024 |
| Cantor Fitzgerald |
| Overweight |
| Overweight |
| maintain |
| 26 Sept 2024 | RBC Capital | Outperform | Outperform | maintain |
| 20 Sept 2024 | Cantor Fitzgerald | Overweight | Overweight | maintain |
| 16 Sept 2024 | Cantor Fitzgerald | Overweight | Overweight | maintain |
| 5 Aug 2024 | Barclays | Overweight | Overweight | maintain |
| 2 Aug 2024 | Wedbush | Neutral | Neutral | maintain |
| 2 Aug 2024 | Cantor Fitzgerald | Overweight | Overweight | maintain |